» Articles » PMID: 18979480

Addressing the PEG Mucoadhesivity Paradox to Engineer Nanoparticles That "slip" Through the Human Mucus Barrier

Overview
Specialty Chemistry
Date 2008 Nov 4
PMID 18979480
Citations 177
Authors
Affiliations
Soon will be listed here.
Citing Articles

Pulmonary Delivery of Nonviral Nucleic Acid-Based Vaccines With Spotlight on Gold Nanoparticles.

Araujo Cirne C, Foldvari M Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025; 17(1):e70000.

PMID: 39800783 PMC: 11725562. DOI: 10.1002/wnan.70000.


Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer.

Fernandez-Garcia R, Fraguas-Sanchez A Pharmaceutics. 2025; 16(12.

PMID: 39771562 PMC: 11677881. DOI: 10.3390/pharmaceutics16121584.


Strategies for intravesical drug delivery: From bladder physiological barriers and potential transport mechanisms.

Li Z, Wen K, Liu J, Zhang C, Zhang F, Li F Acta Pharm Sin B. 2024; 14(11):4738-4755.

PMID: 39664414 PMC: 11628814. DOI: 10.1016/j.apsb.2024.07.003.


Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation.

Zheng Y, Luo S, Xu M, He Q, Xie J, Wu J Acta Pharm Sin B. 2024; 14(9):3876-3900.

PMID: 39309496 PMC: 11413706. DOI: 10.1016/j.apsb.2024.06.015.


A temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment.

Feng S, Zhang Y, Hou C, Liu Y, Gao Y, Song Y Sci Adv. 2024; 10(35):eadn8695.

PMID: 39196940 PMC: 11352908. DOI: 10.1126/sciadv.adn8695.


References
1.
Huang Y, Leobandung W, Foss A, Peppas N . Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J Control Release. 2000; 65(1-2):63-71. DOI: 10.1016/s0168-3659(99)00233-3. View

2.
McAuley J, Linden S, Png C, King R, Pennington H, Gendler S . MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest. 2007; 117(8):2313-24. PMC: 1913485. DOI: 10.1172/JCI26705. View

3.
Lele B, Hoffman A . Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages. J Control Release. 2000; 69(2):237-48. DOI: 10.1016/s0168-3659(00)00303-5. View

4.
Fresta M, Fontana G, Bucolo C, Cavallaro G, Giammona G, Puglisi G . Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir. J Pharm Sci. 2001; 90(3):288-97. DOI: 10.1002/1520-6017(200103)90:3<288::aid-jps4>3.0.co;2-5. View

5.
Bures P, Huang Y, Oral E, Peppas N . Surface modifications and molecular imprinting of polymers in medical and pharmaceutical applications. J Control Release. 2001; 72(1-3):25-33. DOI: 10.1016/s0168-3659(01)00259-0. View